Specialists of the State Scientific Center of Virology and Biotechnology “Vector” have confirmed the effectiveness of the domestic vaccines “Sputnik V” and “Epivakkorona” against the British mutation COVID-19, reports TASS, citing a source in the press service of Rospotrebnadzor.
The report says that in neutralization reactions using sera obtained from citizens vaccinated with Russian drugs, a protective effect was demonstrated.
It is specified that the sera of persons who received the Sputnik V and Epivaccorona vaccines neutralized both the British strain and the usual one.
Earlier it was reported that the head of the Russian Federation Vladimir Putin instructed the government to analyze the effectiveness of domestic vaccines against new strains of coronavirus.
Meanwhile, the specialists of the Center. N.F. Gamalei has developed a technology that will quickly create vaccines against several variants of COVID-1 at once. New development is at an advanced stage. However, it will be possible to move to clinical trials only at the end of 2021. The vaccine drug itself will appear no earlier than 2022.